Ocumetics Technology Corp. Appoints Sandi Gilbert to Board of Directors, Dean Burns Named Chairman

CALGARY, Alberta — October 30, 2026 — Leads & Copy — Ocumetics Technology Corp. announced the appointment of Sandi Gilbert to its Board of Directors and the concurrent appointment of Dean Burns, President and CEO, as Chairman of the Board. Gilbert's return to the board is expected to leverage her capital markets experience to support the company's funding for its next growth phase.

Gilbert is an entrepreneur and venture capitalist specializing in helping organizations scale. She founded DealPoint, a fintech solution that digitizes investor onboarding, investment execution, and compliance for private capital markets. Gilbert also leads InterGen, a not-for-profit connecting emerging companies with business leaders, and serves as Managing Partner of InterGen Capital, a venture fund focused on enabling high-potential companies to access global markets.

Gilbert's experience includes serving on the board of the National Angel Capital Association and as a member of the Alberta Securities Commission's New Economy advisory board. Her appointment as a director is pending approval from the TSX Venture Exchange.

Ocumetics Technology Corp. is a Canadian research and development company focused on advanced vision correction solutions. The company aims to innovate in ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies. Ocumetics is currently in an early feasibility study for a dynamic intraocular lens designed to fit within the eye's natural lens compartment. This technology aims to eliminate the need for corrective lenses by allowing the eye's natural muscle to shift focus from distance to near, providing clear vision at all distances without a perceptible time lag.

Ocumetics Technology Corp. trades on the TSX Venture Exchange as OTC, on the OTCQB as OTCFF, and on the Frankfurt Stock Exchange as 2QBO.

Source: Ocumetics Technology Corp.